Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
1758.10
Change Change %
-51.90 -2.87%

Updated:14 Nov, 2019, 15:58 PM IST

BSE
1758.75
Change Change %
-51.55 -2.85%

Updated:14 Nov, 2019, 16:01 PM IST

Piramal Enterprise, formerly known as Nicholas Piramal, is one of the largest pharmaceutical companies in India. Being part of Piramal Group, its healthcare division contributes 50% to group’s revenue. Besides healthcare, the Piramal Group has business interests in areas of glass manufacturing, retail and real estate.

Piramal Healthcare operates two divisions namely healthcare solutions and pharma solutions. PHL is one of the largest custom manufacturing companies with global presence in North America, Europe and Asia.

Today, operating across multiple verticals within healthcare, life sciences and drug delivery systems, healthcare information management, financial services and contract manufacturing services, the company has diversified further.

Manufacturing facilities

Healthcare solutions– Headquartered in Mumbai, the company has manufacturing facilities located at Baddi in Himachal Pradesh and Mulund in Maharashtra.

Pharma solutions– PHL’s manufacturing units are located at Mahad and Thane in Maharashtra, Ennore in Tamil Nadu, Digwal in Andhra Pradesh, Pithampur in Madhya Pradesh, Morpeth, Grangemouth, Huddersfield and Billingham in the U.K. and Torcan in Canada.

Products and services

Pharma Solutions– This division is engaged in manufacturing of API and formulations in nine therapeutic areas. The company operates one of the leading custom manufacturing businesses in the world, due to this PHL offers a full lifecycle partnership to small/virtual and big pharma. It provides services such as clinical phase APIs, clinical phase formulations and commercial APIs. It also offers packaging solutions.

Healthcare solutions– Under this, PHL has developed multi–ingredient formulations and single–ingredients products.

PHLacquired US–based RxElite Holdings, the inhalation anaesthetic gas distribution arm of RxElite. The acquisition gives Piramal ownership of Holdings' sales and distribution network in the US.

Important events

2011 – Piramal's Pharma Solutions manufacturing site at Grangemouth, Scotland became the world’s first contract supplier at commercial scale for ADCs.

Fortune 500 ranks Piramal Healthcare in the top–50 largest corporations across India.

Ranked #5 out of the top 10 pharmaceutical contract manufacturers worldwide and #1 in India by the ‘UN Conference on Trade and Development’s World Investment Report 2011’.

2012 – Piramal Healthcare Limited renamed to Piramal Enterprises Limited.
Piramal Enterprises Limited acquires molecular imaging development portfolio of Bayer Pharma.

Platinum Award for Manufacturing Excellence by Frost & Sullivan in partnership with the Economic Times in 2012.
                                                                                                     
2013 – Piramal Water (Sarvajal) honoured with ‘Enabling Technology Award of the Year 2013’ by Frost & Sullivan

Top